Cardiotoxicity is a relatively frequent and potentially serious side effect of traditional and
targeted cancer therapies. Both general measures and specific pharmacologic …

Cardiotoxicity is a significant complication of chemotherapeutic agents in cancer patients.
Cardiovascular incidents including LV dysfunction, heart failure (HF), severe arrhythmias …

Cardiotoxicity due to cancer treatment is of rising concern, for both cardiologists and
oncologists, because it may have a significant impact on cancer patient management and …

Advances in oncologic therapies have led to considerable improvements in prognosis and
survival. However, these improvements may ultimately be diminished by the increase of …

Cardiovascular toxicity is a potential short-or long-term complication of anticancer therapy.
Exposure to chemotherapy medications, primarily the anthracycline class, can lead to …

Abstract Purpose of Review Cardiotoxicity is an important complication of cancer therapy.
With a significant improvement in the overall survival and prognosis of patients undergoing …

Drug-induced cardiotoxicity is emerging as an important issue among cancer survivors. For
several decades, this topic was almost exclusively associated with anthracyclines, for which …

Current oncologic treatments have brought a strong reduction in mortality in cancer patients.
However, the cancer therapy-related cardiovascular complications, in particular chemo …

As cancer therapeutics continues to improve and progress, the adverse side effects
associated with anticancer treatments have also attracted more attention and have become …

Cardio-oncology is a recently developed field in cardiology aimed at significantly reducing
cardiovascular morbidity and mortality and improving quality of life in cancer survivors …